טוען...
Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors
OBJECTIVE: To investigate the use of dopamine agonists and monoamine oxidase type B (MAO-B) inhibitors in the Norwegian population, between 1 July 2006 and 31 December 2016. Our primary endpoint was time until need for levodopa among new monotherapy users of dopamine agonists and MAO-B inhibitors. M...
שמור ב:
| הוצא לאור ב: | Parkinsons Dis |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8270692/ https://ncbi.nlm.nih.gov/pubmed/34306611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/9952743 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|